Evidence suggests that a distinct cellular immune signature, characterised by elevated CD27+CD28+ CD4 T cell levels coupled with reduced CD56dim natural killer cells and effector memory CD8 T cell counts, may define the immune profile of individuals with CeD, AITD and T1D [73]. This evidence concerns the gene CD4 and cranioectodermal dysplasia.